Xu H - Search Results

1

Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance.

Ren Y, Mao X, Xu H, Dang Q, Weng S, Zhang Y, Chen S, Liu S, Ba Y, Zhou Z, Han X, Liu Z, Zhang G. Ren Y, et al. Among authors: xu h. Cell Mol Life Sci. 2023 Aug 19;80(9):263. doi: 10.1007/s00018-023-04907-4. Cell Mol Life Sci. 2023. PMID: 37598126 Free PMC article. Review.

2

Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma.

Liu Z, Weng S, Xu H, Wang L, Liu L, Zhang Y, Guo C, Dang Q, Xing Z, Lu T, Han X. Liu Z, et al. Among authors: xu h. Front Oncol. 2021 Oct 25;11:757919. doi: 10.3389/fonc.2021.757919. eCollection 2021. Front Oncol. 2021. PMID: 34760703 Free PMC article.

3

Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer.

Liu Z, Guo C, Dang Q, Wang L, Liu L, Weng S, Xu H, Lu T, Sun Z, Han X. Liu Z, et al. Among authors: xu h. EBioMedicine. 2022 Jan;75:103750. doi: 10.1016/j.ebiom.2021.103750. Epub 2021 Dec 15. EBioMedicine. 2022. PMID: 34922323 Free PMC article.

4

Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types.

Liu Z, Guo C, Li J, Xu H, Lu T, Wang L, Liu L, Han X. Liu Z, et al. Among authors: xu h. Clin Transl Med. 2021 Dec;11(12):e619. doi: 10.1002/ctm2.619. Clin Transl Med. 2021. PMID: 34923755 Free PMC article. No abstract available.

5

Molecular Characterization and Clinical Relevance of ALDH2 in Human Cancers.

Ma B, Liu Z, Xu H, Liu L, Huang T, Meng L, Wang L, Zhang Y, Li L, Han X. Ma B, et al. Among authors: xu h. Front Med (Lausanne). 2022 Jan 13;8:832605. doi: 10.3389/fmed.2021.832605. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35096916 Free PMC article.

6

A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy.

Liu Z, Ren Y, Weng S, Xu H, Li L, Han X. Liu Z, et al. Among authors: xu h. Front Immunol. 2022 Jan 24;13:809761. doi: 10.3389/fimmu.2022.809761. eCollection 2022. Front Immunol. 2022. PMID: 35140720 Free PMC article. Review.

7

Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer.

Liu Z, Liu L, Weng S, Guo C, Dang Q, Xu H, Wang L, Lu T, Zhang Y, Sun Z, Han X. Liu Z, et al. Among authors: xu h. Nat Commun. 2022 Feb 10;13(1):816. doi: 10.1038/s41467-022-28421-6. Nat Commun. 2022. PMID: 35145098 Free PMC article.

8

Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options.

Liu Z, Xu H, Weng S, Ren Y, Han X. Liu Z, et al. Among authors: xu h. Front Immunol. 2022 Jan 27;13:828330. doi: 10.3389/fimmu.2022.828330. eCollection 2022. Front Immunol. 2022. PMID: 35154148 Free PMC article.

9

Gene Expression Profile Reveals a Prognostic Signature of Non-MSI-H/pMMR Colorectal Cancer.

Liu Z, Xu H, Ge X, Weng S, Dang Q, Han X. Liu Z, et al. Among authors: xu h. Front Cell Dev Biol. 2022 Feb 17;10:790214. doi: 10.3389/fcell.2022.790214. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35252170 Free PMC article.

10

Exploring Key Genes to Construct a Diagnosis Model of Dilated Cardiomyopathy.

Zheng Y, Liu Z, Yang X, Weng S, Xu H, Guo C, Xing Z, Liu L, Wang L, Dang Q, Qiu C. Zheng Y, et al. Among authors: xu h. Front Cardiovasc Med. 2022 Apr 27;9:865096. doi: 10.3389/fcvm.2022.865096. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35571180 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,417 results

Search Page

Filters